title: A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection.
abstract: TRIM5α is a factor contributing to intracellular defense mechanisms against retrovirus infection. Rhesus and cynomolgus monkey TRIM5αs potently restrict HIV-1, whereas human TRIM5α shows weak effects against HIV-1. We investigated the association between a single nucleotide polymorphism in the TRIM5α linker 2 region (rs11038628), which substituted aspartic acid (D) for glycine (G) at position 249, with susceptibility to HIV-1 infection in Japanese and Indian subjects. rs11038628 is rare in Europeans but common in Asians and Africans. Functional analyses were performed by multiple-round replication and single-round assays, and indicated that the G249D substitution attenuated anti-HIV-1 activity of human TRIM5α. A slight attenuation of anti-HIV-2 activity was also observed in TRIM5α with 249D. The predicted secondary structure of the linker region suggested that the 249D substitution extended the α-helix in the neighboring coiled-coil domain, suggesting that human TRIM5α with 249D may lose the flexibility required for optimal recognition of retroviral capsid protein. We further analyzed the frequency of G249D in Japanese (93 HIV-1-infected subjects and 279 controls) and Indians (227 HIV-1-infected subjects and 280 controls). The frequency of 249D was significantly higher among HIV-1-infected Indian subjects than in ethnicity-matched control subjects [odds ratio (OR)=1.52, p=0.026]. A similar weak tendency was observed in Japanese subjects, but it was not statistically significant (OR=1.19, p=0.302). In conclusion, G249D, a common variant of human TRIM5α in Asians and Africans, is associated with increased susceptibility to HIV-1 infection.
authors: Department of Viral Infections, Research Institute for Microbial Disease, Osaka University, Osaka, Japan.
authors: Emi E
authors: EE
authors: Nakayama
authors: Toshiaki
authors: T
authors: Nakajima
authors: Gurvinder
authors: G
authors: Kaur
authors: Jun-ich
authors: JI
authors: Mimaya
authors: Hiroshi
authors: H
authors: Terunuma
authors: Narinder
authors: N
authors: Mehra
authors: Akinori
authors: A
authors: Kimura
authors: Tatsuo
authors: T
authors: Shioda
mesh_terms: D019943:Amino Acid Substitution / Q000235:genetics*; D000818:Animals; D000090103:Antiviral Restriction Factors; D015153:Blotting, Western; D002352:Carrier Proteins / Q000235:genetics* / Q000502:physiology; D003001:Cloning, Molecular; D004198:Disease Susceptibility; D005091:Exons / Q000235:genetics; D005838:Genotype; D015658:HIV Infections / Q000235:genetics*; D015497:HIV-1; D006801:Humans; D008253:Macaca mulatta; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D044469:Racial Groups / Q000235:genetics; D000070584:Tripartite Motif Proteins; D044767:Ubiquitin-Protein Ligases
chemical_list: D000090103:Antiviral Restriction Factors; D002352:Carrier Proteins; D000070584:Tripartite Motif Proteins; C477346:TRIM5 protein, human; D044767:Ubiquitin-Protein Ligases
references: Nat Genet. 2004 Jun;36(6):565-74
references: 15167933
references: Adv Enzymol Relat Areas Mol Biol. 1978;47:45-148
references: 364941
references: Retrovirology. 2006 Aug 22;3:54
references: 16925802
references: Curr Biol. 2006 Jan 10;16(1):95-100
references: 16401428
references: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91
references: 15249690
references: J Virol. 2007 Jul;81(13):7280-5
references: 17475650
references: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11827-32
references: 15280539
references: Virology. 2008 Apr 10;373(2):447-56
references: 18201746
references: Curr Biol. 2005 Jan 11;15(1):73-8
references: 15649369
references: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10319-23
references: 9294208
references: Immunogenetics. 2007 Jun;59(6):511-5
references: 17406861
references: PLoS Pathog. 2008 Feb 8;4(2):e18
references: 18248091
references: Int J Hematol. 2006 Jul;84(1):12-7
references: 16867896
references: Science. 1985 Aug 9;229(4713):563-6
references: 2992081
references: Virology. 2006 Oct 10;354(1):15-27
references: 16887163
references: PLoS One. 2012;7(10):e47757
references: 23094081
references: Retrovirology. 2010 Jul 07;7:58
references: 20609213
references: Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5514-9
references: 16540544
references: Immunogenetics. 2007 Oct;59(10):793-8
references: 17874089
references: Viral Immunol. 2005;18(3):500-5
references: 16212528
references: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2832-7
references: 15689398
references: Acta Med Okayama. 1985 Apr;39(2):155-9
references: 2988287
references: J Virol. 2006 Jun;80(11):5631-6
references: 16699044
references: J Virol. 1998 Oct;72(10):8150-7
references: 9733856
references: AIDS. 2010 Jul 31;24(12):1813-21
references: 20588169
references: AIDS. 2009 Oct 23;23(16):2091-100
references: 19710594
references: J Virol. 2005 Jul;79(14):8870-7
references: 15994780
references: J Virol. 2006 Mar;80(5):2463-71
references: 16474153
references: J Virol Methods. 2008 Aug;151(2):249-56
references: 18524394
references: AIDS. 2004 Mar 26;18(5):729-38
references: 15075507
references: J Virol. 2005 Mar;79(5):3139-45
references: 15709033
references: J Virol. 2005 Jul;79(14):8969-78
references: 15994791
references: Nature. 2004 Feb 26;427(6977):848-53
references: 14985764